Home Tags Abbott Rapid Dx International Limited

Abbott Rapid Dx International Limited Related News

albumin-to-creatinine ratio helps identify early kidney disease

The albumin-to-creatinine ratio: shining a light on early kidney disease

Abbott outlines how albumin-to-creatinine ratio measurement can be leveraged to address the increasing global burden of kidney disease. Albumin-to-creatinine ratio (ACR) is known to be...
Fighting forward: how to keep antibiotics working with CRP point-of-care testing

Fighting forward: how to keep antibiotics working with CRP point-of-care testing

Abbott explores how antibiotic use can be reduced in primary care settings and reviews the role of CRP point-of-care testing, its use in different...
point-of-care testing

How point-of-care testing is optimising cardiovascular and diabetes care

Abbott reflects on the anticipated uptake in rapid, point-of-care technology in cardiovascular and diabetes primary care and proposes steps to smooth the transformation from...
point-of-care testing

Advances in point-of-care testing and the importance of connectivity

Felicia Longobardi of Abbott outlines key advances in point-of-care testing and how digital connectivity can be used to improve outcomes within healthcare. In recent years,...
C-reactive protein

CRP rapid testing for suspected COVID-19 could slow the spread of antimicrobial resistance

Dr Carl Llor reviews recent evidence that C-reactive protein (CRP) rapid testing can be used as a prognostic marker in COVID-19 and contribute to...
Point-of-care medicine: the future of rapid diagnostics in healthcare

Point-of-care medicine: the future of rapid diagnostics in healthcare

Abbott explores how point-of-care diagnostics will evolve in the wake of COVID-19, and showcases a new learning platform that aims to transform knowledge on rapid testing in primary care.
The role of point-of-care testing in the time of COVID-19

The role of point-of-care testing in the time of COVID-19

Exploring the value of point-of-care C-reactive protein testing in the time of COVID-19 in patient risk assessment and monitoring. As the healthcare industry’s understanding of...

Pin It on Pinterest